Adolescent HIV/STD Risk-of-Exposure Screen Development

Information

  • Research Project
  • 6523386
  • ApplicationId
    6523386
  • Core Project Number
    R01DA014717
  • Full Project Number
    5R01DA014717-02
  • Serial Number
    14717
  • FOA Number
    RFA-DA-01-07
  • Sub Project Id
  • Project Start Date
    9/30/2001 - 24 years ago
  • Project End Date
    8/31/2006 - 19 years ago
  • Program Officer Name
    JONES, DIONNE
  • Budget Start Date
    9/1/2002 - 23 years ago
  • Budget End Date
    8/31/2003 - 22 years ago
  • Fiscal Year
    2002
  • Support Year
    2
  • Suffix
  • Award Notice Date
    9/30/2002 - 23 years ago
Organizations

Adolescent HIV/STD Risk-of-Exposure Screen Development

DESCRIPTION: (provided by applicant) Human immunodeficiency virus (HIV) and other sexually transmitted diseases (STDs) are major health concerns among adolescents. The adolescent health field has repeatedly requested development of a brief, standardized, reliable and validated adolescent HIV/STD transmission risk screening instrument to be used across sites, settings, interventions, and populations. Thus, the goal of this research is to develop this reliable and valid self-report HIV/STD-risk screen that is developmentally appropriate for administration to adolescents 12 through 19 years of age. This screen will be configured like the widely used, NIDA-developed Problem-Oriented Screening Instrument for Teenagers (POSIT). Toward this goal, a 5-year, multi-site psychometric study will be conducted to: (1) translate the preliminary screen into Spanish; (2) reduce the number of items on the currently available 30-item scale; (3) accumulate diverse evidence for the reliability and validity of the English screen; (4) identify optimal cut scores to differentiate high/medium-from low/medium-risk youth; and (5) accumulate similar psychometric evidence and identify optimal cut scores for the Spanish- language version. The 30-item screen and accompanying battery of validating instruments will be administered using audio, computer-administered self-interview (audio-CASI) technology by a collaborative team of researchers at field sites across the US, initially in English and, after refining, in Spanish. Sites will include outpatient adolescent health clinics and pediatric clinics to target low/medium-risk youth and drug treatment settings, outpatient STD clinics, counseling clinics, and juvenile detention centers to target high/medium-risk youth. Data will be aggregated nationally and reliability analysis and validity analysis-construct, concurrent, and discriminant validity-performed, along with item analysis to reduce the item set so that the most efficient and psychometrically sound screen is retained. Optimal cut scores will be derived using the Minimum Loss function cut score determination method along with estimations of the relative seriousness of making Type I and Type 11 errors.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R01
  • Administering IC
    DA
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    538996
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    279
  • Ed Inst. Type
  • Funding ICs
    NIDA:538996\
  • Funding Mechanism
  • Study Section
    ZDA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NOVA RESEARCH COMPANY
  • Organization Department
  • Organization DUNS
    175358027
  • Organization City
    BETHESDA
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    20814
  • Organization District
    UNITED STATES